Home NDC 61919-515
VALACYCLOVIR
Product NDC 61919-515
11-digit product format 619190515
Labeler code 61919
Product ID 61919-515_874aa629-1333-0c30-e053-2a95a90ac888
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name VALACYCLOVIR
Dosage form TABLET
Route ORAL
Labeler DirectRX
Application ANDA077135
Marketing category ANDA
Marketing start 2019-04-24
Marketing end 0000-00-00
Substance VALACYCLOVIR HYDROCHLORIDE
Active strength 500 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 61919-515-20 VALACYCLOVIR 20 in 1 BOTTLE TABLET 20 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61919-515 VALACYCLOVIR TABLET [DIRECTRX] 1 Legacy NDC, 1 package rows 20190425_874aa629-1332-0c30-e053-2a95a90ac888.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 61919-515-20 61919051520 20 TABLET in 1 BOTTLE (61919-515-20) 20 tablet 2019-04-24 0000-00-00 No No Current